0
0
Read Time:15 Second
The Food & Drug Administration have approved Eisai’s Alzheimer’s drug Leqembi. The drug is a breakthrough drug which is used to slow down cognitive decline in the early stage of the disease. It is expected to cost in the mid $20,000 range for a year’s worth of treatments.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %